May 19, 2026

Side Effects: When More Is Less

A gene variant that raises GLP-1 levels somehow makes GLP-1 drugs work worse. Plus: why your nose might still recover two years out, and what urine might eventually tell us about schizophrenia.

Conexiant

May 18, 2026

Could Digital Twins Forecast Forensic Risk?

Researchers outline a proposed three-level framework spanning patient monitoring, ward operations, and forensic system planning.

Conexiant

May 15, 2026

Urine Markers May Aid Psych Diagnosis

Genetically predicted urinary metabolite levels were associated with schizophrenia, bipolar disorder, attention-deficit/hyperactivity disorder, and anorexia nervosa in a Mendelian randomization analysis.

Conexiant

May 15, 2026

Assessing the Use of Wearable Mobile-Monitoring Devices Among Individuals With Serious Mental Illness: Qualitative Acceptability and Feasibility Study

Journal Of Medical Internet Research (Jmir)

May 14, 2026

Family psychoeducation to support patients with psychotic illness: two-year outcomes from a pre–post longitudinal pilot study

Frontiers In Psychiatry

May 13, 2026

Assessing directional connections between symptoms, cognition, insight, and real-life functioning in schizophrenia: a partial ancestor graphs analysis

Frontiers In Psychiatry

May 13, 2026

Romanian male patients with the dual diagnosis of schizophrenia and alcohol use disorder: a prospective study of clinical, social, and treatment-related factors affecting quality of life

Frontiers In Psychiatry

May 13, 2026

From cats to cortex: T. gondii and psychosis, depression, and anxiety

Frontiers In Psychiatry

May 12, 2026

Artificial intelligence approaches for schizophrenia prediction and its biomarkers using medical imaging data

Frontiers In Psychiatry

May 11, 2026

Stewardship Cuts Steroid Prescribing

Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing

Conexiant